GREGORY A LIZEE to Tumor Escape
This is a "connection" page, showing publications GREGORY A LIZEE has written about Tumor Escape.
Connection Strength
0.309
-
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy. Front Immunol. 2023; 14:1237715.
Score: 0.193
-
NLRC5/MHC class I transactivator is a target for immune evasion in cancer. Proc Natl Acad Sci U S A. 2016 May 24; 113(21):5999-6004.
Score: 0.116